type full_text Care Plan TCU GER Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] fluid status, repeat BNP RP OA, monitor postural blood pressureTCU CGH CVM 27/4/21 Clinical Summary GERIATRIC MEDICINE DISCHARGE SUMMARYSUMMARY 82 year old Chinese female admitted for Fluid overload b/g severe TR cx R LL wound 2' chronic LL edema, and subacute functional decline. Transferred to subacute ward 65 for further rehab and optimisation of fluid status.SOCIALLives with: DaughterMain caregiver: HelperPREMORBID FUNCTIONBathing: IDressing: I Feeding: IMobility and aid, if any: Community ambulant with WC, QS (non ambulant since NTFGH admission)Continent of urine: YContinent of bowels: YPREMORBID COGNITIONNil known dementiaAMT 19/3/21: 7/10 No formal educationPAST MEDICAL HISTORY 1. HTN 2. HLD 3. Bilateral Knee OA, pes planus 4. Hx of e. coli sepsis secondary to right pyelonephritis 5. Gastritis. CLO test ve 6. Right cataract s/p Right Phaco/IOL 7. Iron deficiency anemia OGD/colono done in April 2014: H pylori gastritis, colono NAD on ferrous gluconate 8. AF on rivaroxaban known to CVM CGH 2 DE: LVEF 50 . No RWMA. Severe TR. Pulmonary hypertension (intermediate probability) PASP 50 mmHg 9. Osteoporosis, Vit D 32.8 Started on Denosumab Oct 2020 in view of borderline CrCl for bisphosphonates 10. Left upper limb weakness since birth Last admitted to NTFGH 20 Feb 4 March 2021 (AOR Discharge)i. Right LL cellulitis Right LL venous scan: No DVT. No reflux seen. ii. AOCKDiii. Trop leak 2' cellulitis b/g Hx of severe TRiv. Hyperbilirubinaemia likely 2' TRv. Left LZ Pneumonia PRESENTING COMPLAINTAdmitted to CGH GER from 11/3/21 19/3/21:1. Fluid overload likely secondary to severe TR 2. Right Lower limb ulcers likely 2' chronic lower limb oedema 3. Cholestatic LFT likely hepatic congestion 4. Functional decline Premorbidly ADL indept/ ambulant until 18/2/2021 prior to admission to NTFGH following AOR discharge from NTF, patient has not been ambulant 5. Bone Health: Vit D: 32.8 (Oct 20) Denosumab administered inpatient on 18/3/21 Transferred to Ward 65 SACH for continued rehabilitationSIGNIFICANT PHYSICAL FINDINGSAlert, comfortable at restHS 1 S 2 PSM Lungs: Reduced air entry bilateral bases A soft non tendersacral oedema Calves suppleBilateral pedal oedema up to shinSkin: Right distal Leg ulcer, shin ulcer superficial, nil dischargeBilateral DP pulse / A. ACTIVE ISSUES 1. Fluid overload likely secondary to valvular heart disease TTE 12/3/21: LVEF 55 . No RWMA of LV seen at rest. Severe bi atria dilatation. Aortic valve sclerosis. Moderate degenerative and calcified mitral stenosis. (MVA by pressure half time: 2.37 cm 2, MVA by Planimetry: 1.3 cm 2, MVA by VTI: 0.61 cm 2, MPG: 9 mmHg, Pressure half time: 93 ms) Mild to moderate MR. Dilated TV annulus (38 mm) with moderate to severe TR ( ERO area : 0.47 cm 2) Mild to moderate PR. On IV Frusemide since CGH, continued on 80 mg BD > increased to 80 mg TDS (23 29/3/21) with Metolazone 5 mg (23/3 25/3) > Reduced to PO Frusemide 80 mg TDS (29/3/21) then 80 mg BD (30/3/21) Complicated by AoCKD> Cr 120 s (baseline) > 180 s > 159 (22/3/21) CXR 26/3/21: Largely stable fluid overload status, with marginal interval improvement of the left moderate pleural effusion. The right small pleural effusion remains largely unchanged. IDC inserted on 19/3/21 for strict IO charting (see point 4) Blood pressure borderline SBP 90 100 s Postural BP 97/59>82/50 asymptomatic Referred to CVM on 25/3/21:> Continue IV Frusemide> Resume Bisoprolol 1.25 mg [REDACTED] [REDACTED] [REDACTED] [REDACTED][REDACTED] 5 mg BD), uptitrate once heart failure improves Bisoprolol increased to 2.5 mg OM on discharge Complicated by AoCKD on 31/3/21 likely from overdiuresis> Body weight 65.5 kg (admission to SACH) > 54.35 kg (31/3) > 56 kg (1/4) PO Frusemide 40 mg OM resumed on discharge 2. Right Lower limb ulcers likely 2' chronic lower limb oedema Nil CVI noted on US doppler 2 Mar 2021 (done at NTFGH) AO Scan (16/3): atherosclerotic disease, biphasic flow On wound dressing helper competent 3. Cholestatic LFT likely hepatic congestion US Abdo (15/3/21): Small gallbladder polyp/adherent calculus. Non specific gallbladder wall oedema. No convincing evidence of acute cholecystitis. Sonographic Murphy's sign is negative. No biliary dilatation. Slight irregularity of liver surface could be due to cirrhosis. No solid hepatic mass is seen. ALP 192 GGT 160 (stable)4. Gross haematuria in IDC likely traumatic insertion IDC inserted on 19/3/21 for strict IO charting Noted blood stained urine in IDC on 21/3/21 UFEME RBC 311 WBC 108 EC neg Urine cs 21/3/21: E coli <R> Augmentin, Ampicillin, Cefuroxim, Cephalexin, Ciprofloxacin, Cotrimoxazole, Trimethoprim <s> Fosfomycin, Gentamicin, Nitrofurantoin Klebsiella pneumoniae <r> Ampiciilin, <i> Trimethoprim Antibiotics withheld as patient is asymptomatic, inflammatory markers unremarkable CRP 3.6 TW 5.8 Rivaroxaban withheld on 21/3/21, resumed on 23/3/21 TOC on 31/3/21 successful PVRU 0 ml No further haematuria after TOC 5. Functional decline Premorbidly ADL indept/ ambulant until 18/2/2021 prior to admission to NTFGH following AOR discharge from NTF, patient has not been ambulant Transferred to Ward 65 SACH for continued rehabilitation> Unable to complete adequate rehab as patient keen for home before grandson's wedding> CGT to patient's helper completedFunction on arrival to ward 65 bed mobility , transfer moderate x 1 ambulate with walking frame mod assist x 1 3 4 stepsFunction on discharge from ward 65 Ambulation with rollator frame mod assist x 2, 2 mADLs max assist 6. Bone Health Vit D: 32.8 (Oct 20) Anti resorptive (Alendronate/denosumab) last administered on 16/10/20 Denosumab administered inpatient on 18/3/21 Repeat Ca 26/3/21: 2.397. Social Lives with helper Grandson's wedding on 2 3/4/21, patient keen for home by then For further rehab at day rehab centre Unable to provide H 2 H service as patient moved to Clementi areaPatient discharged well and stable on 1/4/21 B. EXTENT OF CARE AND ACP DISCUSSIONEOC: trial of active (family undecided)ACP: not referredC. CONDITION ON DISCHARGEMental state: Alert, GCS 15 Mobility: Ambulation with rollator frame mod assist x 2, 2 mDiet modifications: NAD. MEDICATION REVIEWReduced Bisoprolol from 5 mg BD to 2.5 mg OM in view of borderline blood pressure, fluid overload Pneumococcal PCV 13: Y 30/11/2018 Pneumococcal PPSV 23:Y 7/9/20 Yearly Influenza: Y 7/9/20 E. TREATMENT GOALSReferred to day rehab Aim for home ambulation with walking frame min mod assistance x 1 F. FOLLOW UP PLANTCU GER Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] fluid status, repeat BNP RP OA, monitor postural blood pressureTCU CGH CVM 27/4/21